CB07-Exatecan

CB07-Exatecan is an ADC drug-Linker conjugate that can be used for the synthesis of ADCs. ADC conjugated with CB07-Exatecan and trastuzumab inhibits the growth of HER2-positive cancer cells.


Cat. No.: EX-A12522	Purity: >98%

	Chemical structure of CB07-Exatecan

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	get quote	inquire
50mg	get quote	inquire
100mg	get quote	inquire
250mg	get quote	inquire
500mg	get quote	inquire
1g	get quote

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


CAS No.	2879247-31-9
Purity	>98%
Formula	C71H94FN11O22
Mol Weight	1472.565
Color	Light yellow to yellow
State	solid
Solubility	Soluble in DMSO
Shelf Life	>3 years if stored properly
Storage	Powder 4℃, sealed storage, away from moisture and light, 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Weijia Tang, et al. Method for treating her2-positive solid tumor. Patent WO2023198079A1. /p>
CoA	CoA of CB07-Exatecan

Smiles:	N(C(OCC1=CC=C(NC([C@@H](NC([C@@H](NC([C@@H](NC(CN2C(=O)C=CC2=O)=O)CCNC(CCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O)C(C)C)=O)CCCNC(N)=O)=O)C=C1)=O)[C@@H]3C4=C5C(C=6N(C5)C(=O)C7=C(C6)[C@](CC)(O)C(=O)OC7)=NC=8C4=C(CC3)C(C)=C(F)C8


		Search